SVA logo

Sinovac Biotech (SVA) Selling, General & Administrative Expenses

Annual SGA

$466.32 M
-$357.22 M-43.38%

December 1, 2023

Summary

Performance

1-Year Change

-43.38%

3-Year Change

+164.16%

5-Year Change

+240.38%

15-Year Change

+433.77%

SVA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.79%
SVA annual SGA is higher than 89.79% of companies in Healthcare sector

High & Low

All-time High

$823.54 M
SVA annual SGA is currently -43.38% below its historical high of $823.54 million

3-Year Low

$466.32 M
SVA annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
SVA previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Aug 15, 2025
SVA next annual earnings announcement is scheduled for Aug 15, 2025

OtherSVAexpensesmetrics:

Annual Total Expenses

$972.57 M
SVA annual total expenses is $972.57 million

Annual Operating Expenses

$791.05 M
SVA annual total operating expenses is $791.05 million

Annual Cost Of Goods Sold

$181.52 M
SVA annual cost of goods sold is $181.52 million

Annual Interest Expense

$2.26 M
SVA annual interest expense is $2.26 million

Quarterly SGA

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

SVA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$83.05 M
SVA quarterly SGA is currently at an all-time high

3-Year Low

-
SVA quarterly SGA 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
SVA previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

Aug 15, 2025
SVA next earnings announcement is scheduled for Aug 15, 2025

OtherSVAexpensesmetrics:

Quarterly Total Expenses

-
SVA quarterly total expenses value is unknown

Quarterly Operating Expenses

-
SVA quarterly total operating expenses value is unknown

Quarterly Cost Of Goods Sold

-
SVA quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
SVA quarterly interest expense value is unknown

TTM SGA

$14.23 B
-$132.30 M-0.92%

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

+11611.86%

SVA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

96.71%
SVA TTM SGA is higher than 96.71% of companies in Healthcare sector

High & Low

All-time High

$14.85 B
SVA TTM SGA is currently -4.20% below its historical high of $14.85 billion

3-Year Low

$12.39 B
SVA TTM SGA is currently +14.81% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
SVA previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

Aug 15, 2025
SVA next earnings announcement is scheduled for Aug 15, 2025

OtherSVAexpensesmetrics:

Annual Total Expenses

$972.57 M
SVA annual total expenses is $972.57 million

Annual Operating Expenses

$791.05 M
SVA annual total operating expenses is $791.05 million

TTM Cost Of Goods Sold

-
SVA TTM cost of goods sold value is unknown

TTM Interest Expense

-
SVA TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$466.32 M
SVA annual SGA is $466.32 million

Annual Operating Expenses

$791.05 M
SVA annual total operating expenses is $791.05 million

Annual Cost Of Goods Sold

$181.52 M
SVA annual cost of goods sold is $181.52 million

SVA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-43.4%--
3 y3 years+164.2%--
5 y5 years+240.4%-+10000.0%

SVA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-43.4%at low-4.2%+14.8%
5 y5-year-43.4%+283.9%-4.2%+8829.0%
alltimeall time-43.4%>+9999.0%-4.2%>+9999.0%

Sinovac Biotech Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2023
$466.32 M(-43.4%)
-
-
Dec 2022
$823.54 M(+39.3%)
-
-
Dec 2021
$591.17 M(+234.9%)
-
-
Dec 2020
$176.53 M(+45.3%)
$83.05 M(+75.8%)
$176.53 M(+39.2%)
Sep 2020
-
$47.23 M(+58.5%)
$126.78 M(+11.3%)
Jun 2020
-
$29.79 M(+80.9%)
$113.95 M(-0.3%)
Mar 2020
-
$16.46 M(-50.6%)
$114.35 M(-5.9%)
Dec 2019
$121.47 M(-11.3%)
$33.30 M(-3.2%)
$121.47 M(-5.7%)
Sep 2019
-
$34.40 M(+14.0%)
$128.87 M(+4.8%)
Jun 2019
-
$30.19 M(+28.0%)
$122.94 M(-10.4%)
Mar 2019
-
$23.58 M(-42.1%)
$137.25 M(+0.2%)
Dec 2018
$137.00 M(+56.8%)
$40.70 M(+42.9%)
$137.00 M(+42.3%)
Sep 2018
-
$28.48 M(-36.0%)
$96.30 M(+42.0%)
Jun 2018
-
$44.50 M(+90.7%)
$67.83 M(+190.7%)
Mar 2018
-
$23.33 M(+53.1%)
$23.33 M(-44.4%)
Dec 2017
$87.36 M(+108.1%)
-
-
Dec 2016
$41.98 M(+12.0%)
$15.24 M(+24.1%)
$41.98 M(+9.2%)
Sep 2016
-
$12.28 M(+48.6%)
$38.45 M(+6.4%)
Jun 2016
-
$8.26 M(+33.3%)
$36.13 M(-2.0%)
Mar 2016
-
$6.20 M(-47.0%)
$36.88 M(-1.6%)
Dec 2015
$37.48 M(+9.2%)
$11.70 M(+17.5%)
$37.48 M(+6.4%)
Sep 2015
-
$9.96 M(+10.5%)
$35.22 M(+4.3%)
Jun 2015
-
$9.01 M(+32.4%)
$33.78 M(+1.3%)
Mar 2015
-
$6.81 M(-27.9%)
$33.35 M(-2.9%)
Dec 2014
$34.34 M(+2.2%)
$9.44 M(+10.9%)
$34.34 M(+3.5%)
Sep 2014
-
$8.52 M(-0.9%)
$33.17 M(-2.6%)
Jun 2014
-
$8.59 M(+10.2%)
$34.05 M(-0.6%)
Mar 2014
-
$7.79 M(-5.8%)
$34.25 M(+2.0%)
Dec 2013
$33.61 M(+1.0%)
$8.28 M(-11.9%)
$33.59 M(-15.5%)
Sep 2013
-
$9.39 M(+6.9%)
$39.73 M(+4.1%)
Jun 2013
-
$8.79 M(+23.1%)
$38.18 M(+5.8%)
Mar 2013
-
$7.14 M(-50.5%)
$36.10 M(+8.5%)
Dec 2012
$33.28 M
$14.41 M(+83.7%)
$33.28 M(+28.3%)
DateAnnualQuarterlyTTM
Sep 2012
-
$7.84 M(+17.1%)
$25.94 M(+0.8%)
Jun 2012
-
$6.70 M(+55.1%)
$25.74 M(+7.2%)
Mar 2012
-
$4.32 M(-39.0%)
$24.02 M(+0.9%)
Dec 2011
$23.81 M(+26.1%)
$7.08 M(-7.4%)
$23.81 M(-1.2%)
Sep 2011
-
$7.64 M(+53.5%)
$24.10 M(+15.5%)
Jun 2011
-
$4.98 M(+21.2%)
$20.87 M(+5.0%)
Mar 2011
-
$4.11 M(-44.3%)
$19.89 M(+5.3%)
Dec 2010
$18.89 M(+4.0%)
$7.37 M(+67.1%)
$18.89 M(+6.4%)
Sep 2010
-
$4.41 M(+10.5%)
$17.75 M(+5.3%)
Jun 2010
-
$3.99 M(+28.5%)
$16.86 M(-4.9%)
Mar 2010
-
$3.11 M(-50.2%)
$17.72 M(-2.4%)
Dec 2009
$18.17 M(+4.9%)
$6.24 M(+77.2%)
$18.17 M(+14.7%)
Sep 2009
-
$3.52 M(-27.6%)
$15.83 M(-1.7%)
Jun 2009
-
$4.86 M(+37.0%)
$16.10 M(-6.8%)
Mar 2009
-
$3.55 M(-9.1%)
$17.28 M(-0.2%)
Dec 2008
$17.31 M(+44.8%)
$3.90 M(+3.0%)
$17.31 M(+9.0%)
Sep 2008
-
$3.79 M(-37.2%)
$15.88 M(-5.8%)
Jun 2008
-
$6.04 M(+68.8%)
$16.85 M(+27.9%)
Mar 2008
-
$3.58 M(+44.7%)
$13.18 M(+37.3%)
Dec 2007
$11.96 M(+22.6%)
$2.47 M(-48.1%)
$9.60 M(+34.7%)
Sep 2007
-
$4.76 M(+101.7%)
$7.12 M(+201.7%)
Jun 2007
-
$2.36 M(+18.0%)
$2.36 M(+18.0%)
Dec 2006
$9.75 M(-5.1%)
-
-
Jun 2006
-
$2.00 M(-21.5%)
$2.00 M(-72.6%)
Dec 2005
$10.28 M(+16.2%)
-
-
Jun 2005
-
$2.55 M(-1.4%)
$7.29 M(+7.4%)
Dec 2004
$8.84 M(+405.7%)
$2.59 M(+19.8%)
$6.79 M(+61.5%)
Sep 2004
-
$2.16 M(+5.3%)
$4.21 M(+105.3%)
Jun 2004
-
$2.05 M
$2.05 M
Dec 2003
$1.75 M(+533.8%)
-
-
Apr 2002
$275.90 K(-43.6%)
-
-
Apr 2001
$489.30 K(+40.1%)
-
-
Apr 2000
$349.20 K
-
-

FAQ

  • What is Sinovac Biotech annual SGA?
  • What is the all time high annual SGA for Sinovac Biotech?
  • What is Sinovac Biotech annual SGA year-on-year change?
  • What is the all time high quarterly SGA for Sinovac Biotech?
  • What is Sinovac Biotech TTM SGA?
  • What is the all time high TTM SGA for Sinovac Biotech?

What is Sinovac Biotech annual SGA?

The current annual SGA of SVA is $466.32 M

What is the all time high annual SGA for Sinovac Biotech?

Sinovac Biotech all-time high annual SGA is $823.54 M

What is Sinovac Biotech annual SGA year-on-year change?

Over the past year, SVA annual SGA has changed by -$357.22 M (-43.38%)

What is the all time high quarterly SGA for Sinovac Biotech?

Sinovac Biotech all-time high quarterly SGA is $83.05 M

What is Sinovac Biotech TTM SGA?

The current TTM SGA of SVA is $14.23 B

What is the all time high TTM SGA for Sinovac Biotech?

Sinovac Biotech all-time high TTM SGA is $14.85 B